Therapeutic options for postmenopausal female sexual dysfunction

被引:52
作者
Al-Azzawi, F. [1 ]
Bitzer, J. [2 ]
Brandenburg, U. [3 ]
Castelo-Branco, C. [4 ]
Graziottin, A. [5 ]
Kenemans, P. [6 ]
Lachowsky, M. [7 ]
Mimoun, S. [8 ]
Nappi, R. E. [9 ]
Palacios, S. [11 ]
Schwenkhagen, A. [10 ]
Studd, J. [12 ]
Wylie, K. [13 ]
Zahradnik, H. -P. [14 ]
机构
[1] Univ Hosp Leicester, Gynaecol Res Unit, Leicester, Leics, England
[2] Univ Basel Hosp, Dept Obstet & Gynecol, CH-4031 Basel, Switzerland
[3] Klin Psychiat & Psychotherapie, Aachen, Germany
[4] Univ Barcelona, Fac Med, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,IDIBAPS, Barcelona 7, Spain
[5] H San Raffaele Resnati, Ctr Gynecol & Med Sexol, Milan, Italy
[6] Free Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands
[7] Hop Xavier Bichat, Paris, France
[8] Robert Debre Hosp, Dept Obstet & Gynecol, Unit Psychosomat Gynecol, Paris, France
[9] Univ Pavia, IRCCS Maugeri Fdn, Res Ctr Reprod Med, I-27100 Pavia, Italy
[10] Ctr Gynecol Endocrinol & Reprod Med, Hamburg, Germany
[11] Inst Palacios Salud & Med Mujer, Madrid, Spain
[12] London PMS & Menopause Ctr, London, England
[13] Porterbrook Clin, Sheffield, S Yorkshire, England
[14] Univ Frauenklin, Klin Endokrinol & Reprod Med, Freiburg, Germany
关键词
FEMALE SEXUAL DYSFUNCTION; MENOPAUSE; ESTROGEN; TESTOSTERONE; DEFICIENCY; PSYCHOSOCIAL; SURGICALLY MENOPAUSAL WOMEN; QUALITY-OF-LIFE; DESIRE DISORDER; AROUSAL DISORDER; DOUBLE-BLIND; TESTOSTERONE PATCH; DEHYDROEPIANDROSTERONE REPLACEMENT; ESTROGEN THERAPY; UNITED-STATES; PREVALENCE;
D O I
10.3109/13697130903437615
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To review the pharmacological and non-pharmacological therapies available for postmenopausal FSD, focusing on practical recommendations for managing postmenopausal women with sexual complaints, through a literature review of the most relevant publications in this field. Psychosocial therapy This type of therapy (basic counselling, physiotherapy and psychosexual intervention) is considered an adaptable step-by-step approach for diagnostic and therapeutic strategies, normally combined with biomedical interventions to provide optimal outcomes. Pharmacological therapy For postmenopausal FSD, many interventional options are now available, including hormonal therapies such as estrogens, testosterone, combined estrogen/testosterone, tibolone and dehydroepiandrosterone. Conclusions Menopause and its transition represent significant risk factors for the development of sexual dysfunction. FSD impacts greatly on a patient's quality of life. Consequently, it is receiving more attention thanks to the development of effective treatments. Non-pharmacological approaches should be used first, focusing on lifestyle and psychosexual therapy. If required, proven effective hormonal and non-hormonal therapeutic options are available.
引用
收藏
页码:103 / 120
页数:18
相关论文
共 71 条
[1]  
[Anonymous], 2003, DIAGN STAT MAN MENT, V4th
[2]   Dehydroepiandrosterone replacement in women with adrenal insufficiency [J].
Arlt, W ;
Callies, F ;
van Vlijmen, JC ;
Koehler, I ;
Reincke, M ;
Bidlingmaier, M ;
Huebler, D ;
Oettel, M ;
Ernst, M ;
Schulte, HM ;
Allolio, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1013-1020
[3]   Drug therapy - Androgens in men - Uses and abuses [J].
Bagatell, CJ ;
Bremner, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :707-714
[4]   Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications [J].
Basson, R ;
Berman, J ;
Burnett, A ;
Derogatis, L ;
Ferguson, D ;
Fourcroy, J ;
Goldstein, I ;
Graziottin, A ;
Heiman, J ;
Laan, E ;
Leiblum, S ;
Padma-Nathan, H ;
Rosen, R ;
Segraves, K ;
Segraves, RT ;
Shabsigh, R ;
Sipski, M ;
Wagner, G ;
Whipple, B .
JOURNAL OF UROLOGY, 2000, 163 (03) :888-893
[5]   Women's sexual function and dysfunction: current uncertainties, future directions [J].
Basson, R. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (05) :466-478
[6]   Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder [J].
Basson, R ;
McInnes, R ;
Smith, MD ;
Hodgson, G ;
Koppiker, N .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (04) :367-377
[7]   Female sexual response: The role of drugs in the management of sexual dysfunction [J].
Basson, R .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (02) :350-353
[8]   Summary of the recommendations on sexual dysfunctions in women [J].
Basson, Rosemary ;
Althof, Stan ;
Davis, Susan ;
Fugl-Meyer, Kirsten ;
Goldstein, Irwin ;
Leiblum, Sandra ;
Meston, Cindy ;
Rosen, Raymond ;
Wagner, Gorm .
JOURNAL OF SEXUAL MEDICINE, 2004, 1 (01) :24-34
[9]   Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder [J].
Berman, JR ;
Berman, LA ;
Lin, H ;
Flaherty, E ;
Lahey, N ;
Goldstein, I ;
Cantey-Kiser, J .
JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) :411-420
[10]   A new non-pharmacological vacuum therapy for female sexual dysfunction [J].
Billups, KL ;
Berman, L ;
Berman, J ;
Metz, ME ;
Glennon, ME ;
Goldstein, I .
JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) :435-441